In addition to reagent and control development, BNC provides Seroxo with specialist consultancy and technical support across research and development, assay optimisation, biosensor and diagnostic technology development, laboratory testing, analytical methods, validation and product development. BNC’s multidisciplinary expertise enables it to support the translation of scientific concepts into robust, reproducible and commercially viable technologies.

Through this partnership, BNC is providing Seroxo with tailored scientific and technical expertise to help optimise the LIT™ platform, address development challenges, improve performance and support the progression of the technology towards further validation, commercialisation and future applications.

BNC’s support can also extend to experimental design, data analysis, technical evaluation, troubleshooting, development of testing protocols and procedures, and the identification and implementation of opportunities for further optimisation and innovation.

This collaboration brings together Seroxo’s proprietary LIT™ technology with BNC’s specialist biotechnology, nanotechnology and product development expertise, providing a strong foundation for the continued development and advancement of Seroxo’s platform.